One-year incidence of psychosocial therapy initiation was 12.6 percent, while incidence of medication initiation was 2.8 percent

Age-dependent U-shaped trajectories seen for depression and anxiety; symptom levels were significantly higher for survivors

REM inhibition via receipt of antidepressant medications associated with trend toward survival benefit

Maximal survival benefit seen for smoking cessation treatment within six months of diagnosis

Caregiver anxiety and neighborhood factors associated with greater symptom burden

Alprazolam reduced IL-6 in human pancreatic cancer-associated fibroblasts and was associated with improved progression-free survival

Threshold effect seen with meaningful benefit for participating in social activity almost every day

Improvements seen in physical and mental health, but survivors still have more symptoms than controls at two years

Life challenges more negatively impacted in younger, female, relapsed patients; socializing more positively impacted in older patients

Authors say these estimates are similar to estimates in hospitalized patients